Answers are grounded in this paper and cite their sources.
Correspondence to Dr Brice Rotureau; rotureau@ pasteur. fr © Author(s) (or their employer(s)) 2022. Reuse permitted under CC BYNC. No commercial reuse. See rights and permissions. Published by BMJ. INTRODUCTION: NEGLECTED TROPICAL DISEASES Neglected tropical diseases (NTDs) represent a group of 20 diseases affecting more than one billion people in 150 countries, mostly in Africa, Asia and the Americas. They are considered as ‘markers of stigma and poverty’, due to their debilitating consequences, also frequently impacting mental health, and because they mainly affect poor, vulnerable and marginalised people. NTDs cause heavy socioeconomic losses at the level of individuals, families, communities and countries. Despite a massive impact that amounts to billions of dollars per year, only 0.6% of the global healthcare funding is allocated to these diseases, disregarding the negative impact of the COVID19 pandemic that is still difficult to quantify. Nevertheless, in the last decade, the consideration of NTDs in global health has evolved and gained momentum. This was heralded by the adoption of the WHO road map for NTDs in 2011, the London Declaration of 2012, the launching of the 2030 Sustainable Development Goals that specifically refer to NTDs, and recently the new 2021–2030 WHO road map on NTDs. These initiatives aimed at drawing stakeholders’ attention to diseases that often remain apart from the main health programme streams: ‘leave no one behind’. In the francophone world, the Organisation Internationale de la Francophonie wrote a specific resolution on NTDs at the Erevan summit of 2018, and the ‘francophone network on NTDs’ has just reiterated its strong support to the new WHO 2030 road map for NTDs. In this road map, specific objectives, including scientific research targets, were set for each NTD according to their epidemiological situation: control, elimination as a public health problem, elimination of transmission and/or eradication (box 1). By definition, NTDs have rarely been prioritised in the research and control actions’ agendas in endemic countries. Traditional vertical intervention schemes have initially been used with success for some NTDs, as for example, the prevention or therapy of geohelminthiases through mass drug administration using cheap, stable and safe oral drugs. However, the intrinsic complexity of pathogens’ life cycles and the limited resources allocated to NTDs have fostered alternative strategies to the classical vertical approaches. Hence, multidisciplinary research approaches at the fundamental, translational and applied levels progressively bloomed in the field of NTDs by necessity, to improve scientific knowledge at the service of control interventions. We believe that lessons from NTDs may SUMMARY BOX
No takes yet. Share an insight, caveat, or question.
Rotureau et al. (2022) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: